CDKL5 Deficiency Disorder: Some Lessons Learned 20 Years After the First Description.

WHAT IT FOUND

This review outlines the clinical features and management consensus for CDKL5 Deficiency Disorder, a severe genetic epilepsy.

It highlights the need for multidisciplinary care and notes that current treatments poorly control seizures and other symptoms, but it reports no new trial results.

What this paper is

This is a narrative review summarizing the history, pathophysiology, and clinical features of CDKL5 Deficiency Disorder. It does not report original data from a specific trial or cohort study, but rather synthesizes existing literature and expert consensus guidelines. While it describes symptoms and care recommendations, it offers no new findings on treatment efficacy or outcomes that would change clinical practice directly.

Read it on PubMed →